B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny
The long-term immunologic effects of B cell depletion with rituximab and the characteristics of the reconstituting B cell pool in lymphoma patients are not well defined, despite the widespread usage of this therapy. Here we report that during the B cell reconstitution phase a majority of the periphe...
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 122(2007), 2 vom: 15. Feb., Seite 139-45 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , |
Format: | Aufsatz |
Sprache: | English |
Veröffentlicht: |
2007
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Rituximab 4F4X42SYQ6 |